Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Margetuximab for the treatment of HER2-positive metastatic breast cancer.
Tarantino P, Morganti S, Uliano J, Giugliano F, Crimini E, Curigliano G. Tarantino P, et al. Among authors: giugliano f. Expert Opin Biol Ther. 2021 Feb;21(2):127-133. doi: 10.1080/14712598.2021.1856812. Epub 2020 Dec 14. Expert Opin Biol Ther. 2021. PMID: 33238772 Free article. Review.
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review.
Trapani D, Giugliano F, Uliano J, Zia VAA, Marra A, Viale G, Ferraro E, Esposito A, Criscitiello C, D'amico P, Curigliano G. Trapani D, et al. Among authors: giugliano f. Breast Cancer Res Treat. 2021 Jun;187(2):323-337. doi: 10.1007/s10549-021-06259-8. Epub 2021 May 27. Breast Cancer Res Treat. 2021. PMID: 34043122 Free article. Review.
Antibody-Drug Conjugates for the Treatment of Breast Cancer.
Corti C, Giugliano F, Nicolò E, Ascione L, Curigliano G. Corti C, et al. Among authors: giugliano f. Cancers (Basel). 2021 Jun 9;13(12):2898. doi: 10.3390/cancers13122898. Cancers (Basel). 2021. PMID: 34207890 Free PMC article. Review.
Harmonizing PD-L1 testing in metastatic triple negative breast cancer.
Giugliano F, Antonarelli G, Tarantino P, Cortes J, Rugo HS, Curigliano G. Giugliano F, et al. Expert Opin Biol Ther. 2022 Mar;22(3):345-348. doi: 10.1080/14712598.2022.2021180. Epub 2021 Dec 29. Expert Opin Biol Ther. 2022. PMID: 34930070 No abstract available.
Systemic Treatment of Ductal Carcinoma In Situ of the Breast.
Crimini E, Corti C, Repetto M, Giugliano F, Antonarelli G, Tarantino P, Zagami P, Morganti S, Nicolò E, Uliano J, Curigliano G. Crimini E, et al. Among authors: giugliano f. Chirurgia (Bucur). 2021 Dec;116(5 Suppl):S97-S104. doi: 10.21614/chirurgia.116.5.suppl.S97. Chirurgia (Bucur). 2021. PMID: 34967317 Free article.
Evolution of low HER2 expression between early and advanced-stage breast cancer.
Tarantino P, Gandini S, Nicolò E, Trillo P, Giugliano F, Zagami P, Vivanet G, Bellerba F, Trapani D, Marra A, Esposito A, Criscitiello C, Viale G, Curigliano G. Tarantino P, et al. Among authors: giugliano f. Eur J Cancer. 2022 Mar;163:35-43. doi: 10.1016/j.ejca.2021.12.022. Epub 2022 Jan 13. Eur J Cancer. 2022. PMID: 35032815
128 results